Last edition
News about "Transcripta Bio"
Transcripta Bio and Synfini Target Huntington's Disease Driver
Transcripta Bio and Synfini use AI-driven chemistry and transcriptome-scale biology to identify a validated Huntington’s disease lead candidate in weeks.
Transcripta Bio | 09/10/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members